L:TSXLoblaw Companies Limited Analysis
Data as of 2026-05-21 - not real-time
CA$61.50
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Loblaw trades at CAD 61.5, sitting just above its 20‑day SMA (≈61.4) and below the 50‑day SMA, with an RSI of 49.7 indicating a neutral momentum environment. The MACD histogram is positive and the signal line is bullish, while volume is on an upward trend, suggesting short‑term buying pressure. However, the DCF‑derived fair value of roughly CAD 41 and a trailing P/E near 28 flag a material valuation gap, even as analysts project a mean target of CAD 67.4. The company posted a Q1 EPS beat (0.52 CAD) but missed revenue expectations, prompting a 4 % share‑price dip and highlighting execution risk. A recent partnership with AI firm Shakudo and a pending normal‑course issuer bid (NCIB) signal strategic investment and confidence from management. The dividend yield sits at 1 % with a modest 25 % payout ratio, supported by strong operating cash flow and a free cash flow generation of over CAD 4 bn. With a beta of –0.28, the stock shows low systematic risk, and its consumer‑defensive grocery niche provides earnings stability.
Overall, the stock offers a blend of defensive fundamentals and modest growth prospects, but the current price appears stretched relative to intrinsic estimates. The ongoing buyback, AI initiatives, and solid balance sheet underpin a bullish outlook, while the recent earnings miss and high volatility (≈25 % 30‑day) temper enthusiasm, suggesting a cautious but positive stance.
Overall, the stock offers a blend of defensive fundamentals and modest growth prospects, but the current price appears stretched relative to intrinsic estimates. The ongoing buyback, AI initiatives, and solid balance sheet underpin a bullish outlook, while the recent earnings miss and high volatility (≈25 % 30‑day) temper enthusiasm, suggesting a cautious but positive stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Q1 earnings miss with revenue shortfall
- Positive MACD and rising volume
- Dividend yield and low payout ratio
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst mean target above current price
- Strategic AI partnership and NCIB buyback
- Stable cash flow and defensive sector positioning
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustainable dividend supported by strong free cash flow
- Low beta and defensive grocery business model
- Valuation gap relative to DCF fair value
Key Metrics & Analysis
Financial Health
Revenue Growth4.20%
Profit Margin4.28%
P/E Ratio27.8
ROE24.49%
ROA7.11%
Debt/Equity151.43
P/B Ratio2.0
Op. Cash FlowCA$6.6B
Free Cash FlowCA$4.1B
Technical Analysis
TrendNeutral
RSI49.7
SupportCA$58.84
ResistanceCA$63.30
MA 20CA$61.39
MA 50CA$62.32
MA 200CA$60.45
MACDBullish
VolumeIncreasing
Fear & Greed Index90.29
Valuation
Fair ValueCA$41.05
Target PriceCA$67.36
Upside/Downside9.53%
GradeOvervalued
TypeBlend
Dividend Yield1.01%
Risk Assessment
Beta-0.29
Volatility25.46%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.